A new analysis comparing the amount of funding invested into stem cell research clearly demonstrates declining...
Up To Date
Latest News
Investors are once again flocking to back biotechs in Europe. Belgian Life Sciences fund Fund+ has raised...
Part microbe, part machine: cyborg bacteria developed at ETH Zurich could revolutionise the biotechnological...
Nordic Nanovector is expanding its foothold in cancer-fighting ADCs. The Oslo-based biotech has inked a...
Trial transparency has been a hotly debated topic over the last months, but now, the EMA is turning words into...
New name, new outlook: blood disorder specialist Dilaforette will be known as Modus Therapeutics Holding from...